We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Owlstone Medical Announces a Novel Approach to Breath-Based Testing for Investigation of the Onset, Progression, and Treatment of Disease

Product News   Jun 19, 2019

 
Owlstone Medical Announces a Novel Approach to Breath-Based Testing for Investigation of the Onset, Progression, and Treatment of Disease
FURTHER INFORMATION
 
 
 

Related Product News

Incorporating Conjugation-Ready Sites into Recombinant Antibodies

Product News

Abcam has announced a partnership with BrickBio, covering the use of BrickBio’s platform for introducing conjugation-ready sites into antibodies and other proteins in both mammalian and bacterial expression systems.

READ MORE

Advancing the Identification of Novel Biomarkers

Product News

Thermo Fisher Scientific and Owlstone Medical have entered into a collaborative partnership to advance the early diagnosis of cancer and other diseases through the discovery and validation of novel biomarkers by non-invasive breath sampling.

READ MORE

Repositive Unveils Molecular Search Functionality for Its Cancer Models Platform

Product News

Repositive has unveiled molecular search functionality for its Cancer Models Platform at ELRIG Drug Discovery.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Diagnostics Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE